- Home
- EYEN vs GNTA Comparison
EYEN vs GNTA Comparison
Compare EYEN & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- GNTA
- Stock Information
- Founded
- EYEN 2014
- GNTA 2014
- Country
- EYEN United States
- GNTA Italy
- Employees
- EYEN N/A
- GNTA N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EYEN Health Care
- GNTA Health Care
- Exchange
- EYEN Nasdaq
- GNTA Nasdaq
- Market Cap
- EYEN 38.2M
- GNTA 67.4M
- IPO Year
- EYEN 2018
- GNTA 2021
- Fundamental
- Price
- EYEN $0.55
- GNTA $5.34
- Analyst Decision
- EYEN Strong Buy
- GNTA Strong Buy
- Analyst Count
- EYEN 2
- GNTA 1
- Target Price
- EYEN $12.00
- GNTA $25.00
- AVG Volume (30 Days)
- EYEN 879.0K
- GNTA 28.4K
- Earning Date
- EYEN 11-11-2024
- GNTA 01-01-0001
- Dividend Yield
- EYEN N/A
- GNTA N/A
- EPS Growth
- EYEN N/A
- GNTA N/A
- EPS
- EYEN N/A
- GNTA N/A
- Revenue
- EYEN $31,405.00
- GNTA N/A
- Revenue This Year
- EYEN $50,309.30
- GNTA N/A
- Revenue Next Year
- EYEN $421.63
- GNTA N/A
- P/E Ratio
- EYEN N/A
- GNTA N/A
- Revenue Growth
- EYEN N/A
- GNTA N/A
- 52 Week Low
- EYEN $0.37
- GNTA $2.20
- 52 Week High
- EYEN $2.57
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- EYEN 52.60
- GNTA 56.89
- Support Level
- EYEN $0.52
- GNTA $4.89
- Resistance Level
- EYEN $0.59
- GNTA $6.20
- Average True Range (ATR)
- EYEN 0.05
- GNTA 0.70
- MACD
- EYEN 0.01
- GNTA -0.06
- Stochastic Oscillator
- EYEN 66.45
- GNTA 37.32
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.